State-wise Status of Multi-Drug Resistant (MDR)/ Rifampicin Resistant (RR) with Additional Resistance Patients Diagnosis and Treatment under National Tuberculosis Elimination Programme (NTEP) in India (2021) | ||||||||
States/UTs | MDR/RR With Additional Resistance Diagnosed | FQ/SLI/InhA/Z Resistance Patients Initiated on Treatment (Other than XDR) | FQ/SLI/InhA/Z Resistance Patients Initiated on Longer Oral Regimen (Other than XDR) | |||||
SLI Resistance | InhA Resistance | Z Resistance | FQ/SLI/InhA /Z Resistance Detected (Other than XDR) | |||||
No. | %age | No. | %age | |||||
Andaman & Nicobar Islands | ||||||||
Andhra Pradesh | ||||||||
Arunachal Pradesh | ||||||||
Assam | ||||||||
Bihar | ||||||||
Chandigarh | ||||||||
Chhattisgarh | ||||||||
Dadra and Nagar Haveli and Daman and Diu | ||||||||
Delhi | ||||||||
Goa | ||||||||
Gujarat | ||||||||
Haryana | ||||||||
Himachal Pradesh | ||||||||
Jammu & Kashmir | ||||||||
Jharkhand | ||||||||
Karnataka | ||||||||
Kerala | ||||||||
Ladakh | ||||||||
Lakshadweep | ||||||||
Madhya Pradesh | ||||||||
Maharashtra | ||||||||
Manipur | ||||||||
Meghalaya | ||||||||
Mizoram | ||||||||
Nagaland | ||||||||
Odisha | ||||||||
Puducherry | ||||||||
Punjab | ||||||||
Rajasthan | ||||||||
Sikkim | ||||||||
Tamil Nadu | ||||||||
Telangana | ||||||||
Tripura | ||||||||
Uttar Pradesh | ||||||||
Uttarakhand | ||||||||
West Bengal | ||||||||
Eastern India | ||||||||
Hindi Belt | ||||||||
North-East India | ||||||||
Northern India | ||||||||
Southern India | ||||||||
Western & Central India | ||||||||
India |